Brain scans reveal Ibogaine's effects on opioid cravings

NCT ID NCT07226570

First seen Nov 10, 2025 · Last updated May 12, 2026 · Updated 25 times

Summary

This study looks at how ibogaine, a plant-based compound, affects brain activity and reduces cravings in people with moderate to severe opioid use disorder. Twenty adults who are already scheduled to receive ibogaine treatment at a licensed clinic in Mexico will undergo brain scans and surveys before and after treatment. Researchers hope to understand how ibogaine works in the brain, which could help develop future treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER (OUD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Susan Samueli Integrative Health Institute, University of California, Irvine

    RECRUITING

    Irvine, California, 92617, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.